A Study to Evaluate the Long Term Safety and Efficacy of Bimekizumab in Subjects With Ankylosing Spondylitis

AS0009 1, Duncansville

As0009 30, Sarasota

AS0009 6, Dallas

As0009 156, Dobrich

As0009 151, Plovdiv

As0009 155, Plovdiv

As0009 150, Rousse

As0009 101, Québec

As0009 205, Brno

As0009 207, Olomouc

As0009 208, Pardubice

As0009 201, Prague

As0009 202, Prague

As0009 211, Prague

As0009 210, Praha 11 Chodov

As0009 203, Zlín

As0009 304, Hamburg

As0009 301, Ratingen

As0009 400, Budapest

As0009 403, Budapest

As0009 401, Veszprém

As0009 466, Bydgoszcz

As0009 453, Elblag

As0009 456, Elblag

As0009 455, Krakow

As0009 461, Lublin

As0009 467, Nowa Sól

As0009 451, Poznan

As0009 450, Torun

As0009 454, Warsaw

As0009 459, Warsaw

As0009 457, Wroclaw

As0009 460, Wroclaw

As0009 465, Wroclaw

As0009 601, Moscow

As0009 604, Moscow

As0009 607, Moscow

As0009 600, Saint Petersburg

As0009 606, Saint Petersburg

As0009 608, Saint Petersburg

As0009 610, Saint Petersburg

As0009 801, A Coruña

As0009 800, Córdoba

As0009 803, Santiago de Compostela

As0009 700, Kyiv

As0009 707, Kyiv

As0009 705, Ternopil

As0009 708, Uzhhorod

As0009 706, Vinnytsia

As0009 704, Zaporizhzhia